Xiang J - Search Results

1

T cell precursor frequency differentially affects CTL responses under different immune conditions.

Ye Z, Ahmed KA, Huang J, Xie Y, Munegowda MA, Xiang J. Ye Z, et al. Among authors: xiang j. Biochem Biophys Res Commun. 2008 Mar 7;367(2):427-34. doi: 10.1016/j.bbrc.2007.12.149. Epub 2008 Jan 4. Biochem Biophys Res Commun. 2008. PMID: 18178159

2

Analysis of the gene expression profiles of immature versus mature bone marrow-derived dendritic cells using DNA arrays.

Chen Z, Gordon JR, Zhang X, Xiang J. Chen Z, et al. Among authors: xiang j. Biochem Biophys Res Commun. 2002 Jan 11;290(1):66-72. doi: 10.1006/bbrc.2001.6147. Biochem Biophys Res Commun. 2002. PMID: 11779134

3

Adenovirus-mediated CD40 ligand gene-engineered dendritic cells elicit enhanced CD8(+) cytotoxic T-cell activation and antitumor immunity.

Liu Y, Zhang X, Zhang W, Chen Z, Chan T, Ali K, Jia Z, Xiang J. Liu Y, et al. Among authors: xiang j. Cancer Gene Ther. 2002 Feb;9(2):202-8. doi: 10.1038/sj.cgt.7700429. Cancer Gene Ther. 2002. PMID: 11857039

4

Antitumor immune responses derived from transgenic expression of CD40 ligand in myeloma cells.

Liu Y, Qureshi M, Xiang J. Liu Y, et al. Among authors: xiang j. Cancer Biother Radiopharm. 2002 Feb;17(1):11-8. doi: 10.1089/10849780252824028. Cancer Biother Radiopharm. 2002. PMID: 11915168

5

Synergistic enhancement of antitumor immunity with adoptively transferred tumor-specific CD4+ and CD8+ T cells and intratumoral lymphotactin transgene expression.

Huang H, Li F, Gordon JR, Xiang J. Huang H, et al. Among authors: xiang j. Cancer Res. 2002 Apr 1;62(7):2043-51. Cancer Res. 2002. PMID: 11929823

6

Engineered fusion hybrid vaccine of IL-4 gene-modified myeloma and relative mature dendritic cells enhances antitumor immunity.

Liu Y, Zhang W, Chan T, Saxena A, Xiang J. Liu Y, et al. Among authors: xiang j. Leuk Res. 2002 Aug;26(8):757-63. doi: 10.1016/s0145-2126(02)00002-4. Leuk Res. 2002. PMID: 12191571

7

Tumour necrosis factor-alpha (TNF-alpha) transgene-expressing dendritic cells (DCs) undergo augmented cellular maturation and induce more robust T-cell activation and anti-tumour immunity than DCs generated in recombinant TNF-alpha.

Zhang W, Chen Z, Li F, Kamencic H, Juurlink B, Gordon JR, Xiang J. Zhang W, et al. Among authors: xiang j. Immunology. 2003 Feb;108(2):177-88. doi: 10.1046/j.1365-2567.2003.01489.x. Immunology. 2003. PMID: 12562326 Free PMC article.

8

Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity.

Liu Y, Huang H, Chen Z, Zong L, Xiang J. Liu Y, et al. Among authors: xiang j. J Gene Med. 2003 Aug;5(8):668-80. doi: 10.1002/jgm.387. J Gene Med. 2003. PMID: 12898636

9

Synergistic effect of lymphotactin and interferon gamma-inducible protein-10 transgene expression in T-cell localization and adoptive T-cell therapy of tumors.

Huang H, Xiang J. Huang H, et al. Among authors: xiang j. Int J Cancer. 2004 May 10;109(6):817-25. doi: 10.1002/ijc.20043. Int J Cancer. 2004. PMID: 15027114

10

Tumor-infiltrating dendritic cell subsets of progressive or regressive tumors induce suppressive or protective immune responses.

Liu Y, Bi X, Xu S, Xiang J. Liu Y, et al. Among authors: xiang j. Cancer Res. 2005 Jun 1;65(11):4955-62. doi: 10.1158/0008-5472.CAN-04-3957. Cancer Res. 2005. PMID: 15930318

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,314 results

Search Page

Filters